NCT01953926 2024-03-12
SUMMIT
Puma Biotechnology, Inc.
Phase 2 Terminated
Clinical Trials
3 trialsNCT00932152 2017-10-19
Fulvestrant and Anastrozole as Consolidation Therapy in Postmenopausal Women With Advanced Non-small Cell Lung Cancer
University of Pittsburgh
Phase 2 Terminated
NCT00592007 2017-06-06
Study Evaluating the Addition of Fulvestrant to Erlotinib in Stage IIIB/IV Non-Small Cell Lung Cancer
University of California, San Diego
Phase 2 Terminated